Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 446 participants.

Also called NCT04590144

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 446 participants (enrolled count) (from the registry)
Sponsor
  • MicroPort CRM Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04590144
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, France, Germany, Italy, Netherlands, Portugal, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04590144. Allocation not applicable; no masking; primary purpose treatment. Start 2021-06-04 (actual); primary completion 2022-03-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)
Acronym
APOLLO
Condition
Ventricular Arrythmia
Condition
Lead
Condition
ICD
Condition
Heart Failure
Intervention (Device)
INVICTA lead
Lead sponsor
MicroPort CRM (class: industry)

Record details

Record id
cardio:ct-nct04590144
Content hash
490e155c1292bd10b0cb1291627ea6b19c24db3abbd7f0c03fe49b09b7615746